E-ISSN: 2584-2986 | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access
International Journal of Antibiotics [2584-2986(e)] is a peer-reviewed open-access journal launched in 2024 that publishes original research articles, reviews, and perspectives in the field of antibiotics and antimicrobial agents. The journal aims to provide a platform for researchers, …
The journal welcomes original research articles, reviews, and perspectives on any aspect of antibiotics and antimicrobial agents, including but not limited to, basic research, clinical trials, epidemiological studies, and policy and practice. The journal also encourages submissions from a broad range of disciplines, including microbiology, pharmacology, immunology, infectious diseases, and public health.
The journal aims to disseminate new knowledge and insights that can contribute to improving the use and effectiveness of antibiotics, as well as to reduce the development and spread of antibiotic resistance.
ijab maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Dr. Cyriac Job, Professor & Head
Email :
Journal: International Journal of Antibiotics
Ensuring the safety and quality of transfusion products is a cornerstone of transfusion medicine.
Diabetes mellitus is one of the most prevalent chronic non-communicable diseases worldwide and represents a major public health challenge due to its long-term complications, increasing prevalence, and economic burden on individuals and healthcare systems.
Antimicrobial resistance (AMR) is one of the major and most intricate threats to the health of the 21st century as it is core to the undermined expertise of the common clinical practice and public health security worldwide.
Lower respiratory tract infections (LRTIs) remain one of the leading causes of morbidity and hospitalization worldwide, particularly among older adults,
immunocompromised individuals, and patients with chronic respiratory disorders.
Antibiotic resistance is now one of the crucial health issues of the world, especially in hospitals where high usage of antimicrobials is increasing the rate at which multi-drug resistant (MDR) organisms appear.
The global escalation of antimicrobial resistance (AMR) has emerged as a critical public health crisis, undermining decades of therapeutic advancements.
